Skip to main content

QUVIVIQ vs Traditional Sleeping Tablets: What's the Difference and Which Is Right for You?

QUVIVIQ vs Traditional Sleeping Tablets: What's the Difference and Which Is Right for You?

QUVIVIQ vs Traditional Sleeping Tablets: What's the Difference and Which Is Right for You?

If you regularly struggle to fall asleep, wake repeatedly during the night or find yourself lying awake for hours, it can be tempting to look for the strongest sleeping tablet available.

But insomnia treatment is not simply about finding a medicine that makes you sleepy.

Different prescription sleep medicines work in different ways and are intended for different circumstances. Traditional sleeping tablets such as zopiclone and zolpidem are generally used for short-term insomnia, while QUVIVIQ (daridorexant) is a newer type of prescription medicine specifically licensed for adults with insomnia symptoms lasting at least three months where daytime functioning is considerably affected.

Understanding those differences can help you have a more informed conversation about insomnia treatment.

At 24 HR Pharmacy, we provide an online chronic insomnia service for suitable adults. Patients complete a clinical assessment which is reviewed by a UK-registered prescriber, with QUVIVIQ considered where clinically appropriate.

What Is Chronic Insomnia?

Everyone has a bad night's sleep occasionally.

Stress, illness, travel, work or major life events can temporarily disrupt sleep without necessarily meaning you have chronic insomnia.

Insomnia can involve:

  • difficulty falling asleep

  • repeatedly waking during the night

  • lying awake for long periods

  • waking earlier than intended

  • feeling tired despite having been in bed

  • difficulty concentrating during the day

  • irritability or reduced daytime functioning

The NHS describes insomnia lasting less than three months as short-term insomnia, while insomnia lasting three months or longer is considered long-term insomnia.

That distinction matters because the appropriate treatment for a few nights of poor sleep may be very different from treatment for someone who has struggled for months.

What Are Traditional Sleeping Tablets?

Several types of medicine have historically been used to manage insomnia.

Among the best known are benzodiazepines and the so-called Z-drugs, which include medicines such as zopiclone and zolpidem.

These medicines broadly work by increasing activity associated with GABA, a chemical messenger that reduces activity within the brain.

The result is a sedative or calming effect that can make it easier to sleep.

For some patients experiencing severe short-term insomnia, these medicines can have a role.

However, they are generally not intended to become an indefinite nightly treatment.

Why Are Zopiclone and Zolpidem Usually Used Short Term?

One of the major limitations of traditional sleeping medicines is the potential for tolerance and dependence.

Tolerance means the body gradually becomes accustomed to a medicine, potentially reducing its effect.

Dependence means the body adapts to the presence of the medicine, which can make stopping treatment more difficult.

The NHS states that zopiclone treatment usually lasts from a few days to a few weeks and is generally not prescribed for longer than four weeks because tolerance can develop and addiction is possible.

Similarly, zolpidem is normally prescribed for only a few days or weeks, up to four weeks, because the body can become accustomed to it and dependence can occur.

Traditional sleeping tablets can also cause next-day effects such as:

  • sleepiness

  • reduced alertness

  • dizziness

  • impaired coordination

This is why prescription sleeping medicines need to be used carefully.

What Is QUVIVIQ?

QUVIVIQ is the brand name for daridorexant.

It is a prescription-only insomnia medicine belonging to a newer class called dual orexin receptor antagonists.

QUVIVIQ is licensed in the UK for adults with insomnia where:

  • symptoms have been present for at least three months, and

  • insomnia has a considerable impact on daytime functioning.

This makes it particularly relevant to chronic insomnia, rather than somebody simply experiencing a few nights of poor sleep.

How Does QUVIVIQ Work?

The biggest difference between QUVIVIQ and traditional sleeping tablets is how it acts in the brain.

To understand this, it helps to understand orexin.

What Is Orexin?

Orexin is part of the brain's natural system for promoting wakefulness.

Think of it as part of your brain's:

"Stay awake" signal.

Daridorexant blocks both orexin-1 and orexin-2 receptors.

By reducing the action of orexin at these receptors, QUVIVIQ reduces wake drive, allowing sleep to occur.

This is different from traditional Z-drugs such as zolpidem, which work through the brain's GABA system to produce a calming or sedating effect.

In very simple terms:

Traditional sleeping tablets → increase inhibitory/calming signalling

QUVIVIQ → reduces wake-promoting signalling

That difference in mechanism is one of the main reasons QUVIVIQ represents a different approach to chronic insomnia treatment.

QUVIVIQ vs Zopiclone and Zolpidem

Here is a simplified comparison:

 

QUVIVIQ (Daridorexant)

Traditional Z-Drugs

Main mechanism

Blocks orexin wake signalling

Acts through GABA-related signalling

Main role

Chronic insomnia

Primarily short-term insomnia

Chronic insomnia licence

Yes

Generally intended for short-term treatment

Treatment duration

Reviewed within 3 months and periodically thereafter

Usually days to weeks

Tolerance/dependence considerations

Different pharmacological profile

Important limitation of prolonged use

Prescription required

Yes

Yes

Clinical assessment required

Yes

Yes

The important message is that these medicines are not simply stronger and weaker versions of the same treatment.

They work differently and may be used for different types of insomnia.

Does QUVIVIQ Help You Fall Asleep?

Clinical trials assessed both sleep onset and sleep maintenance.

Daridorexant was studied in adults with insomnia lasting at least three months and associated daytime impairment.

The trials measured factors including:

  • time to persistent sleep

  • time spent awake after initially falling asleep

  • patient-reported total sleep time

  • daytime functioning

At the licensed 50 mg dose, clinical trial data showed improvements compared with placebo across measures of sleep onset, sleep maintenance, total sleep time and daytime functioning.

This is relevant because chronic insomnia is not always simply a problem with falling asleep.

Some people fall asleep relatively easily but wake repeatedly throughout the night.

Others wake at 3am or 4am and cannot return to sleep.

Does QUVIVIQ Cause Dependence?

This is understandably one of the most common questions from people who have previously used traditional sleeping tablets.

QUVIVIQ works through a different mechanism from benzodiazepines and Z-drugs.

The current UK product information also states that, in clinical studies, no sign of rebound insomnia was observed after discontinuation at the recommended 50 mg dose. QUVIVIQ can be stopped without gradually reducing the dose.

However, this should not be interpreted as meaning the medicine is completely free from risks or suitable for everyone.

It remains a prescription-only medicine requiring appropriate clinical assessment and ongoing review.

What Are the Side Effects of QUVIVIQ?

Like all medicines, QUVIVIQ can cause side effects.

Common adverse reactions listed in the current UK product information include:

  • headache

  • sleepiness

  • dizziness

  • nausea

  • fatigue

Less common effects can include abnormal dreams, nightmares, sleep paralysis, hallucinations and sleepwalking.

Patients should understand how the medicine affects them before driving or carrying out activities requiring full alertness.

Alcohol and other medicines can also be relevant when assessing whether treatment is appropriate.

Who Should Not Take QUVIVIQ?

QUVIVIQ is not appropriate for everyone.

For example, current UK product information states that it must not be used by people with narcolepsy or alongside certain medicines that strongly increase daridorexant levels in the blood. It is also not recommended in severe liver impairment.

A prescriber therefore needs to consider:

  • medical history

  • other medicines

  • liver health

  • alcohol consumption

  • sleep symptoms

  • pregnancy or breastfeeding

  • other possible sleep disorders

This is why prescription insomnia treatment should not simply be selected based on an online comparison table.

What Is the Usual QUVIVIQ Dose?

The recommended adult dose is 50 mg once per night, taken in the evening within approximately 30 minutes before going to bed.

Based on clinical judgement, some patients may receive 25 mg once nightly.

The maximum daily dose is 50 mg.

Treatment should be reviewed rather than continued automatically. The current UK product information recommends assessing whether ongoing treatment remains appropriate within three months and periodically thereafter.

Always follow the instructions provided by your prescriber.

Where Does CBT-I Fit In?

Medication is not the only treatment for chronic insomnia.

Cognitive Behavioural Therapy for Insomnia (CBT-I) aims to address thoughts and behaviours that can maintain insomnia.

This may involve techniques relating to:

  • sleep scheduling

  • stimulus control

  • beliefs and anxiety surrounding sleep

  • behaviours that reinforce insomnia

NICE recommends daridorexant for adults with long-term insomnia when CBT-I has been tried but not worked, or when CBT-I is unavailable or unsuitable.

This is an important distinction.

QUVIVIQ should not be presented as simply the first thing everyone with difficulty sleeping should take.

Why "Sleep Hygiene" Isn't Always Enough

Someone with chronic insomnia may already have tried:

  • avoiding caffeine

  • putting their phone away

  • keeping their bedroom dark

  • going to bed at the same time

  • avoiding alcohol

  • exercising regularly

These measures can support healthy sleep, but chronic insomnia can persist despite good sleep habits.

For some people, the problem becomes a cycle:

Poor sleep → anxiety about sleep → trying harder to sleep → spending longer awake in bed → increased frustration → more difficulty sleeping

This is one reason CBT-I can be particularly useful.

For suitable adults whose insomnia continues despite appropriate approaches, prescription treatment may then be considered.

Which Sleeping Tablet Is Right for You?

There is no single "best sleeping tablet".

The appropriate treatment depends on questions such as:

How long have you had insomnia?

A few nights is very different from six months.

Is your daytime life being affected?

Chronic insomnia can affect concentration, mood, work and everyday functioning.

What have you already tried?

This may include behavioural approaches and CBT-I.

Do you have another sleep disorder?

Heavy snoring, gasping or pauses in breathing may suggest sleep apnoea rather than straightforward insomnia.

What medicines are you taking?

Potential interactions matter.

Do you have other health conditions?

These can influence which treatments are appropriate.

The answer therefore isn't necessarily:

QUVIVIQ is better than zopiclone.

A more useful question is:

Which treatment matches the type and duration of insomnia you are experiencing?

When Should You Seek Professional Help for Insomnia?

Consider seeking professional advice if:

  • you have struggled with sleep for months

  • sleep problems are affecting work or everyday life

  • you regularly struggle to concentrate because of tiredness

  • you experience persistent daytime sleepiness

  • sleep problems are affecting your mood

  • self-help measures have not worked

  • you regularly rely on alcohol or medicines to sleep

  • you think you may have sleep apnoea

  • or you are considering prescription insomnia treatment

The NHS recommends seeking medical advice when changing sleep habits has not helped, insomnia has lasted for months or it is affecting your ability to cope with daily life.

How 24 HR Pharmacy Can Help With Chronic Insomnia

At 24 HR Pharmacy, we provide an online chronic insomnia treatment service for suitable adults.

Our service includes access to QUVIVIQ (daridorexant) where it is clinically appropriate.

The process begins with an online clinical assessment.

We ask about areas such as:

  • how long you have experienced insomnia

  • difficulty falling or staying asleep

  • daytime effects

  • previous insomnia treatments

  • CBT-I and other approaches you have tried

  • medical history

  • current medicines

  • potential contraindications

  • other factors relevant to safe prescribing

Your consultation is then reviewed by a UK-registered prescriber.

Where QUVIVIQ is considered safe and appropriate, treatment can be prescribed and dispensed through our regulated UK pharmacy.

Most importantly, completing a consultation does not automatically mean medication will be prescribed.

If your symptoms suggest another sleep disorder or medical problem requiring further investigation, you may instead be advised to seek appropriate medical assessment.

Why Our Approach Goes Beyond Simply Supplying Sleeping Tablets

The objective of insomnia treatment should not simply be:

"Find something that knocks me out."

A better approach is:

Identify the type of insomnia → understand what may be maintaining it → assess previous treatment → rule out important concerns → consider appropriate treatment → review response

At 24 HR Pharmacy, our chronic insomnia service is designed around this clinical assessment process.

For eligible adults experiencing persistent insomnia lasting at least three months with significant daytime effects, QUVIVIQ offers a different treatment approach from traditional short-term sleeping medicines.

Final Thoughts

QUVIVIQ and traditional sleeping tablets are not simply interchangeable treatments.

Traditional medicines such as zopiclone and zolpidem work primarily through GABA-related pathways and are generally used for short periods because tolerance and dependence can become concerns.

QUVIVIQ (daridorexant) takes a different approach. It blocks orexin receptors, reducing the brain's wake-promoting signalling, and is specifically licensed for adults with insomnia lasting at least three months where daytime functioning is considerably affected.

For people with chronic insomnia, the question therefore should not simply be:

"Which sleeping tablet is strongest?"

It should be:

"Why am I not sleeping, and which treatment is appropriate for my type of insomnia?"

At 24 HR Pharmacy, suitable adults can complete an online chronic insomnia consultation reviewed by a UK-registered prescriber. Where clinically appropriate, QUVIVIQ can be prescribed and supplied as part of an individual treatment approach.

Frequently Asked Questions

Is QUVIVIQ a sleeping tablet?

Yes. QUVIVIQ is a prescription medicine for insomnia containing daridorexant. However, it works differently from traditional Z-drugs by blocking the brain's orexin wakefulness pathway.

Is QUVIVIQ the same as zopiclone?

No. QUVIVIQ contains daridorexant and is a dual orexin receptor antagonist. Zopiclone is a Z-drug that acts through GABA-related signalling. They also have different roles in insomnia treatment.

Is QUVIVIQ for long-term insomnia?

QUVIVIQ is licensed for adults whose insomnia symptoms have been present for at least three months and have a considerable impact on daytime functioning. Continued treatment should be reviewed within three months and periodically thereafter.

How quickly does QUVIVIQ work?

QUVIVIQ is taken within approximately 30 minutes before going to bed. Individual response varies, and chronic insomnia treatment should be assessed based on overall improvements in sleep and daytime functioning rather than simply whether a tablet causes immediate sedation.

What is the normal QUVIVIQ dose?

The recommended adult dose is 50 mg once nightly. Some patients may receive 25 mg based on clinical judgement. The maximum dose is 50 mg per day.

Can I take QUVIVIQ every night?

QUVIVIQ is dosed once nightly when prescribed. The appropriateness of continued treatment should be reviewed within three months and periodically afterwards. Follow the treatment plan provided by your prescriber.

Is QUVIVIQ available online in the UK?

24 HR Pharmacy provides an online chronic insomnia service through which suitable adults can complete a clinical assessment. QUVIVIQ may be prescribed following review by a UK-registered prescriber where treatment is considered clinically appropriate.

Is QUVIVIQ right for everyone with insomnia?

No. It is intended for a specific group of adults with chronic insomnia, and suitability depends on medical history, other medicines, previous treatment and individual circumstances.